Private Equity

Investment firm 4x4 Capital buys Bob Evans Restaurants, aiming to revitalize the iconic American brand with an 'active ownership' strategy.

TransCode Therapeutics and Quantum Leap are targeting hidden cancer cells with a novel RNA drug in a pivotal trial that could prevent colorectal cancer relapse.

Post Holdings names Greg Pearson, a CPG veteran with a history of successful business transformations, to lead its key cereal and pet food division.

BlackRock's integration of Preqin data into its eFront platform creates a single, AI-driven solution, bringing public market transparency to private assets.

With a $375M facility from Eldridge, Atlas Energy is pivoting from proppant to power, aiming to solve the Permian Basin's growing energy crisis.

With backing from top VCs, Angitia Biopharmaceuticals is accelerating its novel treatments for osteoporosis and rare bone disorders. Here's why it matters.

The iconic B.C. snowmobiling retreat has been acquired by new owners who blend Wall Street acumen with a passion for the backcountry.

Main Street Capital and Iron Creek Partners facilitate a buyout of BASELoad, LLC, a key player in healthcare data, signaling a strategic push into this vital sector.

Pharmaceutical giant Fagron expands into packaging in Brazil and raw materials in Hungary, fortifying its end-to-end personalized medicine supply chain.

Forgent Power Solutions prices its IPO at $27 a share, targeting a massive valuation fueled by intense demand from data centers and grid modernization.

Brad Karp's 18-year reign ends abruptly after his ties to Jeffrey Epstein create a 'distraction,' paving the way for dealmaker Scott Barshay to lead.

Everest Medicines bets big on MT1013, a novel dual-action drug poised to transform treatment for millions with chronic kidney disease complications.

The semiconductor giant posted a huge Non-GAAP profit but a stunning IFRS loss for 2025. What's behind the numbers and why are investors cheering?

Shareholders to vote on a US$3.65 per share all-cash deal, a significant premium that will take the growing respiratory care provider private.

The world's largest jeweler misses 2025 growth targets and issues a sober 2026 forecast, prompting a major strategic shift to platinum-plated jewelry.

ExxonMobil acquires a key production vessel in a major strategic shift, while SBM Offshore deleverages in a deal reshaping offshore energy partnerships.

With backing from the D. E. Shaw group, Threadlock Precision's acquisition of Kremin signals a major consolidation in aerospace and defense manufacturing.

Cincinnati's Timber Bay Partners oversubscribes its fund, proving investor appetite for specialized strategies in the booming GP-led secondary market.

Following a major restructuring, FLSmidth appoints Toni Laaksonen as CEO to accelerate growth and capitalize on its new pure-play mining focus.

With acacia gum's supply chain mired in conflict and regulation, a new citrus fiber offers beverage makers a stable, ethical, and cost-effective path forward.